相似文献
1
Use of Medications for Alcohol Use Disorder in the US: Results From the 2019 National Survey on Drug Use and Health.
JAMA Psychiatry. 2021 Jun 16;78(8):922-4. doi: 10.1001/jamapsychiatry.2021.1271.
2
Assessment of Changes in Alcohol and Marijuana Abstinence, Co-Use, and Use Disorders Among US Young Adults From 2002 to 2018.
JAMA Pediatr. 2021 Jan 1;175(1):64-72. doi: 10.1001/jamapediatrics.2020.3352.
3
Drug and alcohol use disorders among adults with select disabilities: The national survey on drug use and health.
Disabil Health J. 2023 Jul;16(3):101467. doi: 10.1016/j.dhjo.2023.101467. Epub 2023 Mar 24.
4
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Subst Abus. 2016 Apr-Jun;37(2):286-98. doi: 10.1080/08897077.2015.1133472.
5
Alcohol, tobacco, and nonmedical drug use disorders in U.S. Adults aged 65 years and older: data from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions.
Am J Geriatr Psychiatry. 2011 Mar;19(3):292-9. doi: 10.1097/JGP.0b013e3181e898b4.
6
Dose-related effects for the precipitation of psychopathology by opioid or tranquilizer/sedative nonmedical prescription use: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
J Addict Med. 2013 Jan-Feb;7(1):39-44. doi: 10.1097/ADM.0b013e318277e9e5.
7
The burden of alcohol use disorders in US military veterans: results from the National Health and Resilience in Veterans Study.
Addiction. 2016 Oct;111(10):1786-94. doi: 10.1111/add.13423. Epub 2016 May 26.
8
Comorbid Alcohol Dependence and Anxiety Disorders: A National Survey.
J Dual Diagn. 2013;9(4). doi: 10.1080/15504263.2013.835164.
9
Psycho-Social Correlates of Opioid Use Disorder among the US Adult Population: Evidence from the National Survey on Drug Use and Health, 2015-2018.
Subst Use Misuse. 2020;55(12):2002-2010. doi: 10.1080/10826084.2020.1788086. Epub 2020 Jul 7.
10
Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Arch Gen Psychiatry. 2004 Apr;61(4):361-8. doi: 10.1001/archpsyc.61.4.361.
引用本文的文献
1
Mapping Dialectical Behavior Therapy Skills to Clinical Domains Implicated in Contemporary Addiction Research: A Conceptual Synthesis and Promise for Precision Medicine.
Cogn Behav Pract. 2024 Sep 7. doi: 10.1016/j.cbpra.2024.07.002.
2
A Preclinical Alcohol BioBank: Samples from Behaviorally Characterized HS Rats for AUD Research.
bioRxiv. 2025 May 7:2025.04.30.651600. doi: 10.1101/2025.04.30.651600.
3
Evaluating the efficacy of valproic acid in alcohol use disorder: a systematic analysis of clinical trials from ClinicalTrials.gov.
Front Pharmacol. 2025 Apr 25;16:1503035. doi: 10.3389/fphar.2025.1503035. eCollection 2025.
4
Alcohol Use Disorder Pharmacotherapy in Patients With Alcohol-Related Liver Disease: A Scoping Review.
Can J Gastroenterol Hepatol. 2025 Apr 3;2025:6455092. doi: 10.1155/cjgh/6455092. eCollection 2025.
5
Prevention of Alcohol-Associated Liver Disease.
Am J Gastroenterol. 2025 Mar 26. doi: 10.14309/ajg.0000000000003427.
6
Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake.
J Clin Invest. 2025 Mar 6;135(9). doi: 10.1172/JCI188314. eCollection 2025 May 1.
7
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.
J Psychoactive Drugs. 2025 Mar 3:1-9. doi: 10.1080/02791072.2025.2474243.
8
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.
JAMA Psychiatry. 2025 Apr 1;82(4):395-405. doi: 10.1001/jamapsychiatry.2024.4789.
9
Bereavement, prolonged grief, and the prevention of alcohol misuse.
Alcohol Clin Exp Res (Hoboken). 2025 Mar;49(3):507-510. doi: 10.1111/acer.15524. Epub 2024 Dec 27.
10
Liver-related mortality in homeless-experienced adults over a 16-year period.
Res Sq. 2024 Nov 27:rs.3.rs-5417681. doi: 10.21203/rs.3.rs-5417681/v1.
本文引用的文献
1
Psychiatric comorbidities in alcohol use disorder.
Lancet Psychiatry. 2019 Dec;6(12):1068-1080. doi: 10.1016/S2215-0366(19)30222-6. Epub 2019 Oct 17.
2
Prevention, screening, and treatment for heavy drinking and alcohol use disorder.
Lancet Psychiatry. 2019 Dec;6(12):1054-1067. doi: 10.1016/S2215-0366(19)30213-5. Epub 2019 Oct 17.
3
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
JAMA. 2018 Aug 28;320(8):815-824. doi: 10.1001/jama.2018.11406.
4
The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder.
Am J Psychiatry. 2018 Jan 1;175(1):86-90. doi: 10.1176/appi.ajp.2017.1750101.
5
Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.
JAMA Psychiatry. 2017 Sep 1;74(9):911-923. doi: 10.1001/jamapsychiatry.2017.2161.
Zotero 插件